RxDoctor Payments Data

Joan Meehan, DO

Family Medicine · Clayton, NCNPI 1437111341

Payments from drug & device makers

$8,861in general payments, 2019–2025

Across 527 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$590
  • Boehringer Ingelheim$517
  • GSK$427
  • plus $4K from 39 others

What the payments were for

  • Food & beverage$8,75199%
  • Education$1101%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,861 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$274,730
Medicare patients
422
Services billed
4,550

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide71$83,636
OzempicSemaglutide52$76,093
JardianceEmpagliflozin78$74,037
FarxigaDapagliflozin Propanediol83$56,541
MounjaroTirzepatide38$38,942
Repatha SureclickEvolocumab56$36,853
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog52$28,995
XareltoRivaroxaban32$26,735
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$26,640
SynthroidLevothyroxine Sodium150$15,072
MyrbetriqMirabegron19$14,658
Tresiba Flextouch U-200Insulin Degludec18$14,585
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr27$13,743
Tresiba Flextouch U-100Insulin Degludec17$11,360
Breo ElliptaFluticasone/Vilanterol27$10,419

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$590$122,578109 claims
Boehringer IngelheimJardiance, Tradjenta$517$81,73193 claims
Novo NordiskOzempic$1,546$76,09352 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Shingrix$427$59,522124 claims
AstraZenecaFarxiga$1,008$56,54183 claims
Johnson & JohnsonXarelto$88$26,73532 claims
AbbVieSynthroid$1,071$15,072150 claims
Astellas Pharma US IncMyrbetriq$279$14,65819 claims
MerckJanuvia$209$6,12612 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$14$3,341380 claims
Sanofi-aventis U.S. LLCLantus$179$1,87614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Clayton

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →